Blog

Prasugrel Fails to Show Noninferiority to Clopidogrel in Stroke
Medscape
PRAGUE, Czech Republic — The antiplatelet agent prasugrel (Effient, Lilly/Daiichi-Sankyo) failed to show noninferiority to clopidogrel (Plavix, Bristol-Myers Squibb) in reducing vascular events among patients with noncardioemboic ischemic stroke, in a …